Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs

Main Article Content

Furio Pirozzi Farina *
Antonella Pischedda
(*) Corresponding Author:
Furio Pirozzi Farina | andro@tin.it

Abstract

Treatment-induced sexual dysfunctions (SD) are a recurrent and controversial topic in recent literature on the adverse events related to the use of 5-alpha-reductase inhibitors (5ARIs) (1, 2). In order to deal adequately with the various aspects of this topic, it is necessary to first cover some of the steps that allow a better definition and understanding of the subject.

Downloads month by month

Downloads

Download data is not yet available.

Article Details